Same Indication

Methotrexate vs Rosuvastatin

Methotrexate vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between Methotrexate and Rosuvastatin.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Rosuvastatin: Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics

Half-life: Methotrexate — 3-10 hours; Rosuvastatin — 19 hours.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5; Rosuvastatin — C22H28FN3O6S.

Molecular Weight: Methotrexate — 454.4400 g/mol; Rosuvastatin — 481.5390 g/mol.

Type: Methotrexate — Small molecule; Rosuvastatin — Small molecule.